Proteomics International Laboratories Ltd. (AU:PIQ) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Proteomics International Laboratories Ltd has announced promising results for its PromarkerEndo blood test, which could revolutionize the diagnosis of endometriosis, a condition affecting millions of women. Published in ‘Human Reproduction,’ the study showcases the test’s high accuracy in identifying all stages of the disease, offering a non-invasive alternative to current diagnostic methods. With potential applications in fertility treatments, the test is poised to significantly impact women’s healthcare and is targeted for launch in Australia by Q2 2025.
For further insights into AU:PIQ stock, check out TipRanks’ Stock Analysis page.